Exploring the New Horizon of AdipoQ in Obesity-Related Alzheimer’s Dementia
Open Access
- 27 January 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
Abstract
Alzheimer’s disease (AD) is the most common form of dementia, which causes abnormalities in learning, thinking, memory, as well as behavior. Generally, symptoms of AD develop gradually and aggravate over time, and consequently severely interfere with daily activities. Furthermore, obesity is one of the common risk factors for dementia. Dysregulation of adipokine and adipocyte dysfunction are assumed to be accountable for the high risk of obesity in people that develop many related disorders such as AD. Moreover, it has been observed that the dysfunction of adipose is connected with changes in brain metabolism, brain atrophy, cognitive decline, impaired mood, neuroinflammation, impaired insulin signaling, and neuronal dysfunction in people with obesity. Conversely, the pathological mechanisms, as well as the molecular players which are involved in this association, have been unclear until now. In this article, we discuss the impact of adiponectin (AdipoQ) on obesity-related Alzheimer’s dementia.This publication has 151 references indexed in Scilit:
- Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer DiseaseArchives of Neurology, 2012
- Adiponectin receptor signalling in the brainBritish Journal of Pharmacology, 2011
- Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3β (GSK-3β)/β-Catenin Signaling CascadeOnline Journal of Public Health Informatics, 2011
- Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β OligomersOnline Journal of Public Health Informatics, 2011
- Adiponectin protects rat hippocampal neurons against excitotoxicityAGE, 2010
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate UptakeNeuron, 2009
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomersProceedings of the National Academy of Sciences of the United States of America, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesOnline Journal of Public Health Informatics, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003